LXRX
Lexicon Pharmaceuticals, Inc. · Healthcare
Invus Public Equities, L.P. bought $3.0M of Lexicon Pharmaceuticals, Inc.
Director and 10% owner
Bought$3,014,123
$12.80Price
235,396Shares
What LXRX did for a copier
Prices for LXRX after this filing aren't in yet.
Invus Public Equities, L.P.'s record
5 other buys with 3 months of prices since 2017: on average −13.9% against the S&P 500, and 2 of 5 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Jun 8. Filed Tue, Jun 12, 2:10 PM ET, during the session. Not investment advice.